LakeShore Biopharma Co. L... (LSB)
2.40
-0.05 (-2.04%)
At close: Feb 20, 2025, 2:21 PM
2.30
-3.99%
After-hours: Feb 20, 2025, 06:22 PM EST
undefined% (undefined)
| Bid | 2.3 |
| Market Cap | 45.71M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2.84 |
| PE Ratio (ttm) | -0.84 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.45 |
| Volume | 7,248 |
| Avg. Volume (20D) | 17,827 |
| Open | 2.40 |
| Previous Close | 2.45 |
| Day's Range | 2.31 - 2.46 |
| 52-Week Range | 1.88 - 11.20 |
| Beta | undefined |
About LSB
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the Uni...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 5, 2021
Employees 758
Stock Exchange NASDAQ
Ticker Symbol LSB
Website https://www.ysbiopharm.com
4 months ago
+21.15%
LakeShore Biopharma shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
+2.5%
LakeShore Biopharma shares are trading higher. The company reported FY24 financial results.
2 months ago · businesswire.com
LSB Industries Announces Publication of 2023 Sustainability ReportOKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB” or “the Company”), (NYSE: LXU) today announced the publication of its 2023 Sustainability Report, highlighting the Company's progress in adv...